AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-82856496/viral-completes-nok15m-offering.html" title="Facts and information about A-VIRAL completes NOK15m offering.(Brief Article)">A-VIRAL completes NOK15m offering.(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from M2 Europharma are available.
Frequently asked questions about RSS feeds
A-VIRAL completes NOK15m offering.(Brief Article)
M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD
The Norwegian biotechnology company A-VIRAL AS reports that it has successfully closed a directed offering of NOK15m.
A-VIRAL, which has research programmes in the areas of virology and autoimmune diseases, intends to use the funds to continue its partnership with CLB Netherlands, a Dutch research …
Related articles from newspapers, magazines, journals, and more
